Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,271

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026

Most affected stateHawaii 200 recalls mention this state

State: MN ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 18, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall United States TerminatedTerminated: February 21, 2025Historical recordClass I

Grimmway Enterprises, Inc. dba Grimmway Farms

Product: --- Organic Baby Carrots --- Organic Baby Carrots 25 Grimmwa…
Reason: Potential contamination with E. coli O121:H19
Published: January 8, 2025
Distribution: Distribution Centers located in U.S. Sta…

View recall →

FDA Recall United States TerminatedTerminated: February 21, 2025Historical recordClass I

Grimmway Enterprises, Inc. dba Grimmway Farms

Product: --- Organic Baby Carrots --- Orangic Baby Peeled Carrots 13/…
Reason: Potential contamination with E. coli O121:H19
Published: January 8, 2025
Distribution: Distribution Centers located in U.S. Sta…

View recall →

FDA Recall United States TerminatedTerminated: February 21, 2025Historical recordClass I

Grimmway Enterprises, Inc. dba Grimmway Farms

Product: --- Organic Baby Carrots --- Organic Baby Peeled Carrots 12/…
Reason: Potential contamination with E. coli O121:H19
Published: January 8, 2025
Distribution: Distribution Centers located in U.S. Sta…

View recall →

FDA Recall United States TerminatedTerminated: February 28, 2025Historical recordClass II

Lithuanian Bakery, Inc.

Product: Chocolate Raspberry: Three sizes, 1. Small, Net Wt 1.25 lbs…
Reason: Products contain undeclared allergens (milk, soy, peanut, and wheat) and undeclared sulfites, yellow 5, yellow 6, and red 40)
Published: January 8, 2025
Distribution: Distributed to store front customers at…

View recall →

FDA Recall United States TerminatedTerminated: February 28, 2025Historical recordClass I

Lithuanian Bakery, Inc.

Product: Napoleonas Torte packaged under the following sizes: 1. Sm…
Reason: Products contain undeclared allergens (milk, soy, and wheat) and undeclared sulfites, yellow 5, yellow 6.
Published: January 8, 2025
Distribution: Distributed to store front customers at…

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA

by RemedyRePack Inc.

Reason: CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 10, 2025Historical recordClass II

Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40

by Curium US, LLC

Reason: Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.

by Breckenridge Pharmaceutical, Inc

Reason: CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.

by Breckenridge Pharmaceutical, Inc

Reason: CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01

by Glenmark Pharmaceuticals Inc., USA

Reason: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08

by Amerisource Health Services LLC

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04

by Amerisource Health Services LLC

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05

by Amerisource Health Services LLC

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04

by Amerisource Health Services LLC

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Published: January 1, 2025
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 14, 2025Historical recordClass II

Borsari Food Company Inc

Product: BORSARI Food Company Incorporated; BLOODY MARY MIX ; 32 FL.…
Reason: Product contains undeclared fish (anchovy) and soy.
Published: January 1, 2025
Distribution: Multiple states

View recall →

FDA Recall United States TerminatedTerminated: March 3, 2025Historical recordClass II

Zoe US, Inc.

Product: ZOE brand Daily 30+ Prebiotic blend; Dietary Supplement; 500…
Reason: Product may contain foreign objects: small metal pieces and/or stones
Published: January 1, 2025
Distribution: Arizona, California, Colorado, Connectic…

View recall →

FDA Recall OngoingHistorical recordClass II

Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.

by Macleods Pharmaceuticals Ltd

Reason: Failed Impurities/Degradation Specifications
Published: December 25, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 27, 2025Historical recordClass II

PROFESSIONAL Regener-Eyes, Ophthalmic Solution (glycerin 0.5%) , 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-003-01

by Regenerative Processing Plant, LLC

Reason: Lack of Sterility Assurance
Published: December 25, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 27, 2025Historical recordClass II

LITE Regener-Eyes, Ophthalmic Solution (glycerin 0.4%), 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-006-01

by Regenerative Processing Plant, LLC

Reason: Lack of Sterility Assurance
Published: December 25, 2024
Distribution: Nationwide

View recall →

Data last updated: October 18, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.